vs
自然阳光（NATR）与Purple Innovation, Inc.（PRPL）财务数据对比。点击上方公司名可切换其他公司
Purple Innovation, Inc.的季度营收约是自然阳光的1.1倍（$140.7M vs $123.8M），自然阳光净利率更高（3.3% vs -2.3%，领先5.6%），Purple Innovation, Inc.同比增速更快（9.1% vs 4.7%），自然阳光自由现金流更多（$7.6M vs $-7.8M），过去两年Purple Innovation, Inc.的营收复合增速更高（8.3% vs 5.6%）
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌，由安迪·莱维特创立，每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道，对比美式标准餐食，该品牌每份餐包的碳排放量可降低72%，主打低碳环保的纯植物饮食方案。
NATR vs PRPL — 直观对比
营收规模更大
PRPL
是对方的1.1倍
$123.8M
营收增速更快
PRPL
高出4.3%
4.7%
净利率更高
NATR
高出5.6%
-2.3%
自由现金流更多
NATR
多$15.4M
$-7.8M
两年增速更快
PRPL
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $140.7M |
| 净利润 | $4.1M | $-3.2M |
| 毛利率 | 72.5% | 41.9% |
| 营业利润率 | 4.3% | -1.6% |
| 净利率 | 3.3% | -2.3% |
| 营收同比 | 4.7% | 9.1% |
| 净利润同比 | 1379.4% | 62.1% |
| 每股收益（稀释后） | $0.23 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NATRPRPL
| Q4 25 | $123.8M | $140.7M | ||
| Q3 25 | $128.3M | $118.8M | ||
| Q2 25 | $114.8M | $105.1M | ||
| Q1 25 | $113.2M | $104.2M | ||
| Q4 24 | $118.2M | $129.0M | ||
| Q3 24 | $114.6M | $118.6M | ||
| Q2 24 | $110.6M | $120.3M | ||
| Q1 24 | $111.0M | $120.0M |
净利润NATRPRPL
| Q4 25 | $4.1M | $-3.2M | ||
| Q3 25 | $5.3M | $-11.7M | ||
| Q2 25 | $5.3M | $-17.3M | ||
| Q1 25 | $4.7M | $-19.1M | ||
| Q4 24 | $-321.0K | $-8.5M | ||
| Q3 24 | $4.3M | $-39.2M | ||
| Q2 24 | $1.3M | $27.0K | ||
| Q1 24 | $2.3M | $-50.2M |
毛利率NATRPRPL
| Q4 25 | 72.5% | 41.9% | ||
| Q3 25 | 73.3% | 42.8% | ||
| Q2 25 | 71.7% | 35.9% | ||
| Q1 25 | 72.1% | 39.4% | ||
| Q4 24 | 72.0% | 42.9% | ||
| Q3 24 | 71.3% | 29.7% | ||
| Q2 24 | 71.4% | 40.7% | ||
| Q1 24 | 71.2% | 34.8% |
营业利润率NATRPRPL
| Q4 25 | 4.3% | -1.6% | ||
| Q3 25 | 7.0% | -10.2% | ||
| Q2 25 | 3.7% | -13.5% | ||
| Q1 25 | 5.4% | -13.9% | ||
| Q4 24 | 3.8% | -6.0% | ||
| Q3 24 | 4.6% | -39.5% | ||
| Q2 24 | 5.1% | -12.1% | ||
| Q1 24 | 4.2% | -19.3% |
净利率NATRPRPL
| Q4 25 | 3.3% | -2.3% | ||
| Q3 25 | 4.2% | -9.9% | ||
| Q2 25 | 4.6% | -16.5% | ||
| Q1 25 | 4.2% | -18.4% | ||
| Q4 24 | -0.3% | -6.6% | ||
| Q3 24 | 3.8% | -33.1% | ||
| Q2 24 | 1.2% | 0.0% | ||
| Q1 24 | 2.1% | -41.8% |
每股收益（稀释后）NATRPRPL
| Q4 25 | $0.23 | $0.03 | ||
| Q3 25 | $0.30 | $0.11 | ||
| Q2 25 | $0.28 | $0.16 | ||
| Q1 25 | $0.25 | $0.18 | ||
| Q4 24 | $-0.02 | $0.08 | ||
| Q3 24 | $0.23 | $0.36 | ||
| Q2 24 | $0.07 | $0.00 | ||
| Q1 24 | $0.12 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.9M | $24.3M |
| 总债务越低越好 | — | $126.7M |
| 股东权益账面价值 | $161.6M | $-29.7M |
| 总资产 | $261.1M | $296.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NATRPRPL
| Q4 25 | $93.9M | $24.3M | ||
| Q3 25 | $95.6M | $32.4M | ||
| Q2 25 | $81.3M | $34.2M | ||
| Q1 25 | $86.5M | $21.6M | ||
| Q4 24 | $84.7M | $29.0M | ||
| Q3 24 | $78.7M | $23.4M | ||
| Q2 24 | $68.7M | $23.4M | ||
| Q1 24 | $77.8M | $34.5M |
总债务NATRPRPL
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
股东权益NATRPRPL
| Q4 25 | $161.6M | $-29.7M | ||
| Q3 25 | $166.7M | $-26.9M | ||
| Q2 25 | $163.7M | $-15.6M | ||
| Q1 25 | $167.1M | $1.3M | ||
| Q4 24 | $161.0M | $20.2M | ||
| Q3 24 | $162.6M | $28.0M | ||
| Q2 24 | $156.4M | $66.4M | ||
| Q1 24 | $159.7M | $65.5M |
总资产NATRPRPL
| Q4 25 | $261.1M | $296.3M | ||
| Q3 25 | $264.8M | $302.1M | ||
| Q2 25 | $254.9M | $303.8M | ||
| Q1 25 | $252.7M | $293.8M | ||
| Q4 24 | $240.9M | $307.8M | ||
| Q3 24 | $245.3M | $309.3M | ||
| Q2 24 | $235.8M | $362.1M | ||
| Q1 24 | $247.3M | $382.1M |
负债/权益比NATRPRPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | $7.6M | $-7.8M |
| 自由现金流率自由现金流/营收 | 6.1% | -5.5% |
| 资本支出强度资本支出/营收 | 1.9% | 1.4% |
| 现金转化率经营现金流/净利润 | 2.41× | — |
| 过去12个月自由现金流最近4个季度 | $28.8M | $-41.9M |
8季度趋势，按日历期对齐
经营现金流NATRPRPL
| Q4 25 | $9.9M | $-5.8M | ||
| Q3 25 | $18.5M | $-968.0K | ||
| Q2 25 | $4.3M | $-4.0M | ||
| Q1 25 | $2.6M | $-23.1M | ||
| Q4 24 | $12.2M | $6.8M | ||
| Q3 24 | $9.6M | $1.1M | ||
| Q2 24 | $1.3M | $-8.9M | ||
| Q1 24 | $2.2M | $-16.8M |
自由现金流NATRPRPL
| Q4 25 | $7.6M | $-7.8M | ||
| Q3 25 | $16.8M | $-1.8M | ||
| Q2 25 | $3.0M | $-7.0M | ||
| Q1 25 | $1.5M | $-25.3M | ||
| Q4 24 | $10.0M | $5.7M | ||
| Q3 24 | $7.9M | $101.0K | ||
| Q2 24 | $-2.0M | $-11.0M | ||
| Q1 24 | $-1.5M | $-19.9M |
自由现金流率NATRPRPL
| Q4 25 | 6.1% | -5.5% | ||
| Q3 25 | 13.1% | -1.5% | ||
| Q2 25 | 2.6% | -6.6% | ||
| Q1 25 | 1.3% | -24.3% | ||
| Q4 24 | 8.5% | 4.4% | ||
| Q3 24 | 6.9% | 0.1% | ||
| Q2 24 | -1.9% | -9.2% | ||
| Q1 24 | -1.4% | -16.5% |
资本支出强度NATRPRPL
| Q4 25 | 1.9% | 1.4% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 1.2% | 2.8% | ||
| Q1 25 | 1.0% | 2.2% | ||
| Q4 24 | 1.9% | 0.8% | ||
| Q3 24 | 1.5% | 0.9% | ||
| Q2 24 | 3.0% | 1.7% | ||
| Q1 24 | 3.3% | 2.5% |
现金转化率NATRPRPL
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | -330.22× | ||
| Q1 24 | 0.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
